ImpactU - Detalle del Producto

Fundadores:

Producto desarrollado por:

@colav
Contacto

ImpactU:

Información:

ImpactU Versión 3.11.2
Última actualización:
Interfaz de Usuario: 16/10/2025
Base de Datos: 29/08/2025
Hecho en Colombia

Real-World Effectiveness and Tolerability of Pazopanib as First Targeted Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Chart Review in Latin America

Acceso Abierto

Idioma: Inglés

Publicado: 19/10/2019

APC (est): No disponible

Abstract no disponible

Renal cell carcinoma treatment

FuenteAdvances in Therapy	Cuartil año de publicaciónNo disponible	Volumen36
Issue12	Páginas3446 - 3457	pISSNNo disponible
ISSN1865-8652	Perfil OpenAlexhttps://openalex.org/S27230875

Scholar citations URL	https://scholar.google.com/scholar?cites=15936228898724855037&as_sdt=2005&sciodt=0,5&hl=en	Openalex URL	https://openalex.org/W2981005844	Scholar URL	https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=info%3A_TzP57_bKN0J%3Ascholar.google.com&btnG=
Doi URL	https://doi.org/10.1007/s12325-019-01109-y	Pdf URL	https://www.researchgate.net/profile/Saul-Campos-Gomez/publication/336673491_Real-World_Effectiveness_and_Tolerability_of_Pazopanib_as_First_Targeted_Therapy_in_Metastatic_Renal_Cell_Carcinoma_A_Retrospective_Chart_Review_in_Latin_America/links/5e069aaa92851c83649fcbc9/Real-World-Effectiveness-and-Tolerability-of-Pazopanib-as-First-Targeted-Therapy-in-Metastatic-Renal-Cell-Carcinoma-A-Retrospective-Chart-Review-in-Latin-America.pdf	Pmid URL	https://pubmed.ncbi.nlm.nih.gov/31630333
Open_access URL	https://figshare.com/articles/figure/Real-World_Effectiveness_and_Tolerability_of_Pazopanib_as_First_Targeted_Therapy_in_Metastatic_Renal_Cell_Carcinoma_A_Retrospective_Chart_Review_in_Latin_America/9897311/1/files/18018407.pdf

Artículo de revista